Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using beta blockers after MI in the elderly.

J Danforth, T A Ports

    Geriatrics
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Beta blockers offer significant benefits for patients after myocardial infarction (MI), irrespective of infarct location or symptoms. Continued use is recommended for at least 1-2 years, or indefinitely for those with angina or hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
    Same author

    Expanded school mental health services: assessing needs related to school level and geography.

    Community mental health journal·2000
    Same author

    Intensive lifestyle changes for reversal of coronary heart disease.

    JAMA·1998
    Same author

    Combined PTCA and aortic valvuloplasty for acute myocardial infarction complicated by severe aortic stenosis and cardiogenic shock.

    Catheterization and cardiovascular diagnosis·1997
    Same author

    Frequency, duration, magnitude, and consequences of myocardial ischemia during intracoronary ultrasonography.

    American heart journal·1997
    Same author

    Accuracy of Doppler catheter measurements: effect of inhomogeneous beam power distribution on mean and peak velocity.

    Journal of the American College of Cardiology·1997
    Same journal

    A new method of local treatment of rheumatoid and traumatic affections of the joints.

    Geriatrics·2010
    Same journal

    Cardiovascular deterioration.

    Geriatrics·2010
    Same journal

    Some prophylactic suggestions regarding the science of geriatrics.

    Geriatrics·2010
    Same journal

    The senile and prematurely senile skin.

    Geriatrics·2010
    Same journal

    Guillain-Barré's disease in the older age group.

    Geriatrics·2010
    Same journal

    Pancreatitis in geriatric practice.

    Geriatrics·2010
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Post-myocardial infarction (MI) management often involves assessing the long-term benefits of cardiovascular medications.
    • Beta-blocking agents have been studied for their efficacy in improving outcomes for patients following an MI.

    Purpose of the Study:

    • To evaluate the benefits of beta-blocking agents in patients post-myocardial infarction (MI).
    • To provide guidance on the duration of beta blocker therapy after MI.

    Main Methods:

    • Analysis of data from the Beta-Blocker Heart Attack Trial (BHAT).
    • Review of findings from the Norwegian timolol trial.

    Main Results:

    • Beta-blocking agents demonstrate significant benefits for post-MI patients.

    Related Experiment Videos

  • Benefits are observed regardless of infarct location, presence of ventricular arrhythmias, or heart failure.
  • General agreement exists on continuing beta blockers for at least 1-2 years in asymptomatic post-MI patients.
  • Conclusions:

    • Beta blockers are beneficial for post-MI patients, including those with symptoms or risk factors.
    • Extended use of beta blockers is recommended for post-MI patients, particularly those with angina or hypertension.